Integrated Filing — IndAS

General information about company
Scrip Code	543433
NSE Symbol	HPAL
MSEI Symbol	NOTLISTED
ISIN	INE0GSL01024
Name of company	HP ADHESIVES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	13-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Manufacturing of Adhesives and Sealants
Start date and time of board meeting	13-May-2025   15:55:00
End date and time of board meeting	13-May-2025   17:48:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-12
Indicate Company website link for updated RPT policy of the Company	https://www.hpadhesives.com/investor-relations/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Company has not defaulted payment of any loan and has not issued any debt securities.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	661865000	2512464000
	Other income	14953000	44822000
	Total income	676818000	2557286000
2	Expenses
(a)	Cost of materials consumed	338508000	1298737000
(b)	Purchases of stock-in-trade	85338000	328756000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-8054000	-45583000
(d)	Employee benefit expense	92184000	340121000
(e)	Finance costs	5906000	21498000
(f)	Depreciation, depletion and amortisation expense	12469000	47048000
(f)	Other Expenses
1	Other Expenses	97796000	334859000
	Total other expenses	97796000	334859000
	Total expenses	624147000	2325436000
3	Total profit before exceptional items and tax	52671000	231850000
4	Exceptional items	0	0
5	Total profit before tax	52671000	231850000
6	Tax expense
7	Current tax	5967000	42659000
8	Deferred tax	5523000	10788000
9	Total tax expenses	11490000	53447000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	41181000	178403000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	41181000	178403000
17	Other comprehensive income net of taxes	-1171000	-969000
18	Total Comprehensive Income for the period	40010000	177434000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	183749000	183749000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		1655015000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.45	1.94
	Diluted earnings (loss) per share from continuing operations	0.45	1.94
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	0.45	1.94
	Diluted earnings (loss) per share from continuing and discontinued operations	0.45	1.94
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notes to the Standalone financial results for the quarter and year ended March 31, 2025 ntttt n1) The above standalone financial results of the Company have been reviewed by the Audit Committee and then approved by the Board of Directors at their respective meetings held on May 13, 2025. Management has exercised necessary due diligence to ensure that the financial results for these periods provide a true and fair view of the Company's affairs. ntttt n2) This statement has been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read with Rule 3 of Companies (Indian Accounting Standards) Rules, 2015 and relevant amendment rules thereafter and other recognised accounting practices and policies to the extent applicable. ntttt n3) The Company operates primarily in adhesives & sealants segment, hence there is only one reportable business segment viz. “Adhesives & Sealants Products”. Accordingly no separate disclosures have been made for segment reporting under Ind AS 108. ntttt n4) During the year ended March 31, 2022 Company has completed the Initial Public Offering (IPO) and details of utilization of IPO Proceeds of Rs. 9669.12 Lakhs (adjusted with final share of company's share issue expenses) till the end of relevant quarter are as follows: ntttt nObjects of the Issue (INR Lakhs)tIPO Proceeds (Net of IPO Expenses)tUtilisation upto March 31st, 2025tUnutilised as on March 31st, 2025 (*) nFunding working capital requirements of the Companyt 5,400.00 t 5,400.00 t - nFunding Capital expenditure(CAPEX)t 2,550.86 t 2,313.56 t 237.30 nGeneral corporate Purposes (As revised upon finalisation of IPO Expenses)t 1,718.26 t 1,718.26 t - nTotalt 9,669.12 t 9,431.82 t 237.30 n(*) Balance of IPO proceeds as at March 31, 2025 are kept in fixed deposits with scheduled commerical banks. ntttt n5) The above Cash flow has been prepared under the Indirect method set out in Indian Accounting Standard Ind AS-7 on statement of Cash Flow. ntttt n6) Previous periods/quarter figures have been regrouped/reclassified wherever necessary. The impact of such reclassification/ regrouping is not material to the financial statements. ntttt n7) The Statement includes the results for the quarter ended March 31, 2025 & March 31, 2024 being the balancing figure between the audited figures in respect of the full financial year ended March 31 and the published unaudited year-to-date figures up to the third quarter of the relevant financial year. ntttt n8) The results for the quarter ended March 31, 2025 are available on the Bombay Stock Exchange of India Limited website (URL: https://www.bseindia.com/corporates) and the National Stock Exchange of India Limited website (URL: https://www.nseindia.com/corporates). n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	707386000
	Capital work-in-progress	43659000
	Investment property	0
	Goodwill	0
	Other intangible assets	1472000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	28596000
	Total non-current financial assets	28596000
	Deferred tax assets (net)	0
	Other non-current assets	41975000
	Total non-current assets	823088000
2	Current assets
	Inventories	561493000
	Current financial asset
	Current investments	227339000
	Trade receivables, current	417775000
	Cash and cash equivalents	30563000
	Bank balance other than cash and cash equivalents	15929000
	Loans, current	10169000
	Other current financial assets	0
	Total current financial assets	701775000
	Current tax assets (net)	11292000
	Other current assets	177539000
	Total current assets	1452099000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	2275187000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	183749000
	Other equity	1655015000
	Total equity attributable to owners of parent	1838764000
	Non controlling interest
	Total equity	1838764000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	6824000
	Total non-current financial liabilities	6824000
	Provisions, non-current	7992000
	Deferred tax liabilities (net)	9512000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	24328000
	Current liabilities
	Current financial liabilities
	Borrowings, current	56878000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	57451000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	172062000
	Total Trade payable	229513000
	Other current financial liabilities	78425000
	Total current financial liabilities	364816000
	Other current liabilities	17640000
	Provisions, current	29639000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	412095000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	436423000
	Total equity and liabilites	2275187000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement gains / (losses) on defined benefit plans	-1565000	-1295000
	Total Amount of items that will not be reclassified to profit and loss	-1565000	-1295000
2	Income tax relating to items that will not be reclassified to profit or loss	-394000	-326000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-1171000	-969000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			231850000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			2579000
	Adjustments for decrease (increase) in inventories			-84595000
	Adjustments for decrease (increase) in trade receivables, current			-43059000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			16255000
	Adjustments for other financial assets, current			-78552000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			73537000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			4225000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			47048000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			17124000
	Adjustments for provisions, non-current			1088000
	Adjustments for other financial liabilities, current			15699000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-8687000
	Adjustments for dividend income			0
	Adjustments for interest income			12590000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-11193000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-5999000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-67120000
	Net cash flows from (used in) operations			164730000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			67758000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			96972000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			20100000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			2569000
	Purchase of property, plant and equipment			137704000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			12590000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			53198000
	Net cash flows from (used in) investing activities	-89447000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			-51634000
	Payments of lease liabilities			7947000
	Dividends paid			27562000
	Interest paid			878000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			15247000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			22772000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			22772000
	Cash and cash equivalents cash flow statement at beginning of period			7791000
	Cash and cash equivalents cash flow statement at end of period			30563000

Signatory Details
Name of signatory	Karan Motwani
Designation of person	Managing Director
Place	Mumbai
Date	13-May-2025